![Bryan Ball](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Ball
Technik-/Wissenschafts-/F&E-Leiter bei
WHITEHAWK THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 30.06.2026
Profil
Bryan Ball is currently Chief Technical Operations Officer at Whitehawk Therapeutics, Inc. since 2024.
Former positions include Chief Quality Officer at Immunomedics, Inc., Chief Quality Officer & Senior VP-Operations at Intercept Pharmaceuticals, Inc. from 2021 to 2022, Vice President-Global Quality at Ikaria, Inc. from 2012 to 2015, Vice President-Quality & Regulatory at Ben Venue Laboratories, Inc., and SVP-Global Quality, Environmental Health & Safety at Mallinckrodt LLC from 2015 to 2019.
Education includes undergraduate studies at Central Michigan University, an MBA from Westminster School, and graduate studies at The University of North Carolina at Charlotte.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2026 | 448’126 ( 0.95% ) | 2 Mio $ | 30.06.2026 |
Aktive Positionen von Bryan Ball
| Unternehmen | Position | Beginn |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2024 |
Ehemalige bekannte Positionen von Bryan Ball
| Unternehmen | Position | Ende |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Geschäftsführer | 01.08.2022 |
Mallinckrodt LLC
 Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01.01.2019 |
| IKARIA, INC. | Corporate Officer/Principal | 01.01.2015 |
Ben Venue Laboratories, Inc.
 Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures sterile liquid products | Corporate Officer/Principal | - |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Bryan Ball
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures sterile liquid products | Health Technology |
Central Michigan University
 Central Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Westminster School
 Westminster School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt LLC
Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Wählen Sie MarketScreener 
